Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04000802
Recruitment Status : Completed
First Posted : June 27, 2019
Last Update Posted : October 17, 2019
Sponsor:
Information provided by (Responsible Party):
Moroccan Society of Surgery

Brief Summary:

Nowadays, the recommended approach for decision-making for oncology patients is based on multidisciplinary meetings (MDT). However, the quality of decision-making during MDT depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).


Condition or disease Intervention/treatment
Decision Making Quality of Health Care Neoplasms/Therapy Patient Care Team Behavioral: response to questionnary

Detailed Description:

Multidisciplinary cancer meetings are a multidisciplinary discussion and decision-making process for a patient with cancer. It allows a sharing of knowledge and decision-making, taking into account the opinion of all the specialists involved in the treatment of cancer, in order to propose the best possible decision for the patient. Nevertheless, the quality of decision-making during CPR depends on other factors such as the quality of presentation of clinical cases, the degree of participation of different specialists and the dynamics of meetings.

There are several validated tools for the quantitative assessment of the decision-making mode during CPRs. The best known is the Metric Of Decision-Making (MDT-MODe). MDT-MODe is a validated tool for the observational evaluation of teamwork and the quality of decision-making during cancer CPR.

MDT-MODe is designed to encourage teams to make holistic decisions tailored to each patient and allows an observer to assess, on a case-by-case basis, in a quantitative and objective way:

The quality of the clinical information (antecedents, radiological pathologies, pathological, comorbid, psychosocial problems and patients' points of view) Contribution to decision-making in teams of key professional groups (surgeons, physicians, oncologists, nurses, health professionals, radiologists, pathologists) Taken together, these notes provide an indication of the quality of team decision-making.

In this study, the investigators will evaluate the decision-making during digestive oncology MDT using the validated "Metric Of Decision-Making" tool (MDT-MODe), in the national institute of oncology (Rabat, Morocco).


Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Prospective Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers
Actual Study Start Date : May 23, 2019
Actual Primary Completion Date : July 4, 2019
Actual Study Completion Date : September 1, 2019

Intervention Details:
  • Behavioral: response to questionnary
    No intervention. Observational study


Primary Outcome Measures :
  1. MODE-MDT scores [ Time Frame: 60 days from the multidisciplinary team meeting ]
    The scores of the Metric Of Decision-Making tool during multidisciplinary team meeting for digestive cancer. The instrument include 10 questions rated from 1 to 5. Higher scores indicate better results. The instrument include questions about the quality of clinical information (History, radiological, pathological, comorbid health conditions, psychosocial issues, and patients' views) and the contribution to team decision making of key professional groups (Surgeons, physicians, oncologists, nurses, allied healthcare professionals, radiologists, pathologists and MDT coordinators) ans a question about the decision (Clear, deferred, no decision. Each question is analyzed separately (mean, median, standard deviation, quartiles).


Secondary Outcome Measures :
  1. Decision reached [ Time Frame: 60 days from the multidisciplinary team meeting ]
    The rate of cases with decisions during multidisciplinary team meetings (Clear decision about treatment in the MODE-MDT instrument).

  2. Decision factors [ Time Frame: 60 days from the multidisciplinary team meeting ]
    Predictive factors for reaching a clear decision about treatment during multidisciplinary team meetings. The factors analyzed are the question of the MODE-MDT instrument.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Observations were carried out at digestive oncology multidisciplinary meetings at The National Institute of Oncology in Rabat, Morocco. The meetings are held once a week.

The study will be performed between the 23rd of May and the 4th of July 2019.

Criteria

Inclusion Criteria:

  • All consecutive cases presented during multidisciplinary cancer meeting for digestive cancer.

Exclusion Criteria:

  • Cases not registered in the electronic health record system.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04000802


Locations
Layout table for location information
Morocco
National Institut of oncology
Rabat, Morocco, 10100
Sponsors and Collaborators
Moroccan Society of Surgery

Layout table for additonal information
Responsible Party: Moroccan Society of Surgery
ClinicalTrials.gov Identifier: NCT04000802     History of Changes
Other Study ID Numbers: MODE_INO
First Posted: June 27, 2019    Key Record Dates
Last Update Posted: October 17, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No